AbbVie’s ABBV 2024 revenue grew 4.6% on a constant currency basis, with 2025 guidance of 5.7% growth and new 2027 guidance for combined sales of immunology drug Skyrizi and Rinvoq of $31 billion (up ...

Regardless of sociodemographic or clinical characteristics, children with food allergy face a significant psychosocial burden ...

A team of international researchers led by scientists at City of Hope have demonstrated a way to boost thymic function after ...

In an increasingly interconnected world, global health faces constant threats from new and re-emerging pathogens. Recent devastating outbreaks of diseases ...

Significant racial disparities persisted in genetic testing for inborn errors of immunity despite the removal of financial barriers, according to a study published in The Journal of Allergy and ...

AbbVie Inc.'s stock rose 4% early Friday, after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology drugs delivered growth needed to ...

Plasma cells (PCs) are the terminal differentiation stage of activated B cells and serve as crucial effector cells in humoral immunity. While PCs have ...

A groundbreaking Japanese study finds a strong link between newborn gut bacteria and food allergies, suggesting probiotic ...